MENU
OZEM
ETF ticker: NASDAQ
PRICE
CHANGE
NET ASSETS

OZEM stock forecast, quote, news & analysis

The investment seeks to provide capital appreciation... Show more

Category: #Health
OZEM
Daily Signal:
Gain/Loss:
A.I.Advisor
published price charts
Interact to see
Advertisement
A.I.Advisor
a Summary for OZEM with price predictions
Jun 22, 2026

OZEM in +1.11% Uptrend, advancing for three consecutive days on May 29, 2026

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where OZEM advanced for three days, in of 137 cases, the price rose further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 20 cases where OZEM's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on June 22, 2026. You may want to consider a long position or call options on OZEM as a result. In of 22 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for OZEM just turned positive on June 15, 2026. Looking at past instances where OZEM's MACD turned positive, the stock continued to rise in of 20 cases over the following month. The odds of a continued upward trend are .

OZEM may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

OZEM moved below its 50-day moving average on June 01, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for OZEM crossed bearishly below the 50-day moving average on May 20, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 6 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where OZEM declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for OZEM entered a downward trend on June 16, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Eli Lilly & Co (NYSE:LLY), AstraZeneca PLC (NYSE:AZN), Amgen (NASDAQ:AMGN), Gilead Sciences (NASDAQ:GILD), Pfizer (NYSE:PFE), Regeneron Pharmaceuticals (NASDAQ:REGN).

Industry description

The investment seeks to provide capital appreciation. The fund's manager will invest at least 80% of its net assets (plus any borrowings for investment purposes) in the equity securities of GLP-1 & Weight Loss Companies or any derivative instruments (such as swap agreements or forward contracts) that utilize one or more GLP-1 & Weight Loss Companies as the reference asset. The fund is non-diversified.

Market Cap

The average market capitalization across the Roundhill GLP-1 & Weight Loss ETF ETF is 115.87B. The market cap for tickers in the group ranges from 217.51M to 982.77B. LLY holds the highest valuation in this group at 982.77B. The lowest valued company is KROS at 217.51M.

High and low price notable news

The average weekly price growth across all stocks in the Roundhill GLP-1 & Weight Loss ETF ETF was 22%. For the same ETF, the average monthly price growth was 56%, and the average quarterly price growth was 96%. BHVN experienced the highest price growth at 28%, while CORT experienced the biggest fall at -4%.

Volume

The average weekly volume growth across all stocks in the Roundhill GLP-1 & Weight Loss ETF ETF was 25%. For the same stocks of the ETF, the average monthly volume growth was 62% and the average quarterly volume growth was 86%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 38
P/E Growth Rating: 74
Price Growth Rating: 49
SMR Rating: 71
Profit Risk Rating: 70
Seasonality Score: 20 (-100 ... +100)
View a ticker or compare two or three
OZEM
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Category Health

Profile
Details
OZEM in +1.11% Uptrend, advancing for three consecutive days on May 29, 2026